Endocrinology

A new class of medication, known as sodium- glucose transporter-2 (SGLT2) inhibitors, is associated with lower rates of death and hospitalisation for heart failure when used to treat patients with type 2 diabetes according to a study presented at the ADA conference.

Severe obesity in high-risk youth correlates directly to increased incidence of type 2 diabetes

The risk of developing type 2 diabetes by age 20 was 12 times as high in severely obese American Indian children aged five to nine years as in normal- weight youth in that age range, according to a study presented at the ADA congress.

New LEADER trial analysis shows reduction in cardiovascular risk in people with type 2 diabetes

New findings from a post-hoc analysis of the LEADER cardiovascular (CV) outcomes trial were presented recently at the 77th annual Scientific Sessions of the American Diabetes Association (ADA).

Long-acting oral insulin tablet provides comparable glycaemic control to insulin glargine injection

A long-acting, oral insulin tablet has been found to safely improve glycaemic control as effectively as the common, injected insulin glargine in people with type 2 diabetes according to a study presented at the ADA.

DEVOTE trial: long-acting insulin results

Results of the DEVOTE trial investigating the cardiovascular (CV) safety profile of long-acting insulin, insulin degludec (Tresiba), in adults with type 2 diabetes were presented at the ADA congress.

Local hospitals improve diabetes referrals and patient care

A new system for making sure inpatients with diabetes get the care they need is improving diabetes healthcare at Sandwell and West Birmingham Hospitals NHS Trust, according to findings of a project presented at the Diabetes UK Professional Conference.

CPD features

Ménière’s disease in the older patient

Ménière’s is an episodic and fluctuant disease with a chronic course. Presentation is a combination of intermittent episodes of vertigo, tinnitus, aural fullness and sensorineural hearing loss.

Hypoglycaemia in older adults living with diabetes

In older people, hypoglycaemia is an under recognised disorder and observational work suggests it is associated with significant increases in cardiovascular and cerebrovascular risks.

The challenge of managing type 2 diabetes in the older patient

The management of diabetes in older patients poses a real challenge due to the delayed and nonspecific presentation and associated other comorbidities.

The role of insulin in Alzheimer's disease

There is an increasing awareness of the importance of insulin in the development of Alzheimer's disease (AD) suggesting that AD may represent a brain-specific form of diabetes and could thus be classified as type 3 diabetes.

Diabetes Knowledge: could do better, try harder

New research from Diabetes UK has found that only a small percentage of the UK public are aware of how life-changing this condition can be. Everyone needs to be aware that diabetes is a serious condition with serious consequences, which is becoming more common.

Diabetes and severe mental illness

People with a severe mental illness die 15–20 years earlier than they would have done, had they not had a severe mental illness. The principle cause of this increased mortality is from long-term conditions such as diabetes, cardiovascular disease, respiratory disease and cancer.

More endocrinology features...

Sign In

Confirm

Endocrinology

Call for papers: Endocrinology